The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 3,575 |
| Depreciation and amortization | 8,320 |
| Impairment of capitalized software development costs | 516 |
| Stock-based compensation expense | 44,144 |
| Common stock warrant expense | 8,762 |
| Credit loss expense | 1,963 |
| Loss on debt extinguishment | 0 |
| Amortization of debt discount and issuance costs | 152 |
| Change in fair value of convertible notes derivative liability | 0 |
| Deferred income taxes | 3,146 |
| Other | 30 |
| Accounts receivable | -10,237 |
| Other current and long-term assets | -3,444 |
| Accounts payable | 355 |
| Due to third-party publishers | -13,619 |
| Accrued expenses | -1,253 |
| Deferred revenue | -2,029 |
| User redemption liability | -8,485 |
| Other current and long-term liabilities | 8,778 |
| Net cash provided by operating activities | 95,274 |
| Additions to property and equipment | 20,293 |
| Additions to capitalized software development costs | 14,010 |
| Maturities of short-term investments | 0 |
| Net cash (used in) provided by investing activities | -34,303 |
| Proceeds from exercise of stock options | 9,124 |
| Debt issuance costs | 2 |
| Proceeds from initial public offering, net | 0 |
| Purchase of treasury stock | 232,971 |
| Taxes paid related to net share settlement of equity awards | 3,420 |
| Deferred offering costs | 0 |
| Proceeds from employee stock purchase plan | 3,220 |
| Other financing activities | 0 |
| Net cash (used in) provided by financing activities | -224,049 |
| Net change in cash, cash equivalents, and restricted cash | -163,078 |
| Cash, cash equivalents, and restricted cash, beginning of period | 349,690 |
| Cash, cash equivalents, and restricted cash, end of period | 186,612 |
Ibotta, Inc. (IBTA)
Ibotta, Inc. (IBTA)